These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2439577)

  • 41. Inefficacy of immunosuppressive treatment in HBSAg-positive, delta-negative, moderate chronic active hepatitis in children.
    Vajro P; Orso G; D'Antonio A; Greco L; Fontanella A; Loffredo G; Oggero V; Buffolano W
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):26-31. PubMed ID: 3884766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
    Torrani Cerenzia MR; Fiume L; Busi C; Mattioli A; Di Stefano G; Gervasi GB; Brunetto MR; Piantino P; Verme G; Bonino F
    J Hepatol; 1994 Feb; 20(2):307-9. PubMed ID: 7516363
    [No Abstract]   [Full Text] [Related]  

  • 47. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
    Guerre J; Gaudric M; Couturier D; Levy C
    Presse Med; 1983 Mar; 12(12):743-6. PubMed ID: 6220311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 49. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: effect on viral replication and on liver cell damage.
    Hess G; Manns M; Hütteroth TH; Meyer zum Büschenfelde KH
    Digestion; 1987; 36(1):47-54. PubMed ID: 3556804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virus-associated receptors for polymerized human serum albumin (RpHSA) in patients with chronic active hepatitis B treated with recombinant leukocyte A interferon.
    Gerken G; Manns M; Hess G; Meyer zum Büschenfelde KH
    Digestion; 1987; 37(2):96-102. PubMed ID: 3040500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
    Ouzan D; Degos F; Marcellin P; Linberg J; Chevallier M; Degott C; Bréchot C; Chossegros P; Weiss AM; Hirtz J
    Gastroenterol Clin Biol; 1987; 11(8-9):568-73. PubMed ID: 3308617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A controlled trial of acyclovir in stable chronic HBsAg, HBeAg-positive carriers.
    Alexander GJ; Fagan EA; Hegarty JE; Rolando N; Guarner P; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S123-7. PubMed ID: 3298404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
    Rakela J; Redeker AG; Weliky B
    Gastroenterology; 1983 May; 84(5 Pt 1):956-60. PubMed ID: 6832570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of chronic hepatitis due to hepatitis B virus.
    Sherlock S; Thomas HC
    Lancet; 1985 Dec; 2(8468):1343-6. PubMed ID: 2866396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S189-92. PubMed ID: 3598156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.
    Wong DK; Cheung AM; O'Rourke K; Naylor CD; Detsky AS; Heathcote J
    Ann Intern Med; 1993 Aug; 119(4):312-23. PubMed ID: 8328741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
    Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.